about
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is current...
Read More
3.84
-0.09
(-2.29%)
4.5M
XNAS Volume
XNAS 24 Jun, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Mannkind Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..